Berghoff v. GlaxoSmithKline, LLC et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
| Florida Southern District Court | |
| Judge: | Robin L Rosenberg |
| Referred: | Bruce E Reinhart |
| Case #: | 9:24-cv-80474 |
| Nature of Suit | 365 Torts - Personal Injury - Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Apr 16, 2024 |
| Terminated: | Apr 16, 2024 |
| Case in other court: | California Northern, 3:24-cv-01880 |
| Last checked: Sunday Oct 13, 2024 5:08 AM EDT |
|
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Boehringer Ingelheim U.S.A. Corporation
|
Represented By
|
|
Defendant
GlaxoSmithKline LLC
|
Represented By
|
|
Defendant
Patheon
|
|
|
Defendant
Pfizer Inc
|
Represented By
|
|
Defendant
Sanofi-Aventis U.S. LLC
|
Represented By
|
|
Plaintiff
Irwin Berghoff
|
Represented By
|
| Docket last updated: 11 hours ago |
| Wednesday, June 05, 2024 | ||
| 30 | 30
notice
Notice of Voluntary Dismissal - aty
Wed 06/05 6:20 PM
NOTICE of Voluntary Dismissal without prejudice by Irwin Berghoff (Parekh, Behram) |
|
| Tuesday, April 16, 2024 | ||
| 29 | 29
4
pgs
order
Order Staying Case
Tue 04/16 2:47 PM
PRETRIAL ORDER # 80 Procedures for the Filing of All Future Claims in this MDL. Case is Administratively Closed and Stayed. Signed by Judge Robin L. Rosenberg on 4/16/2024. See attached document for full details. (jas) |
|
| 28 | 28
transfer
MDL Tag-Along/Transfer In Case Receipt
Tue 04/16 2:31 PM
MDL Transfer In Case Receipt from Northern District of California. Case Number 24-cv-01880-TLT with documents 1-25. Assigned FLSD Case Number 24-cv-80474-RLR. Re: FLSD MDL Case Number 20-md-2924-RLR (jas) |
|
| 27 | 27
order
Clerk's Notice of Judge Assignment and Optional Consent
Tue 04/16 2:29 PM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Bruce E. Reinhart. (jas) |
|
| 26 | 26
transfer
Case Transferred In - District Transfer - CV - NO FEE
Tue 04/16 1:51 PM
Case transferred in from California Northern; Case Number 3:24-cv-01880. Electronic file including transfer order and docket sheet received. .(jas) |
|
| Monday, April 15, 2024 | ||
| case electronically transmitted to Southern District of Florida. (tn, COURT STAFF) | ||
| Friday, April 12, 2024 | ||
| 25 | 25
CONDITIONAL TRANSFER ORDER (CTO125) by the United States Judicial Panel on Multidistrict Litigation TRANSFERRING CASE to the United States District Court for the Southern District of Florida, MDL No. 2924. (tn, COURT STAFF)
|
|
| Wednesday, April 10, 2024 | ||
| 24 | 24
ORDER GRANTING 9 MOTION TO STAY ALL PROCEEDINGS PENDING TRANSFER TO MULTIDISTRICT LITIGATION. Signed by Judge Trina L Thompson on 4/9/2024. (rfm, COURT USER)
|
|
| Monday, April 08, 2024 | ||
| 23 | 23
Renotice motion hearing re9 MOTION to Stay All Proceedings Pending Transfer to Multidistrict Litigation filed byGlaxoSmithKline, LLC. (Bhimani, Jay)
|
|
| Friday, April 05, 2024 | ||
| 22 | 22
Certificate of Interested Entities by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation identifying Corporate Parent Boehringer Ingelheim International GMBH for Boehringer Ingelheim USA Corporation; Corporate Parent Boehringer Ingelheim Corporation, Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc.. DEFENDANT BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. AND BOEHRINGER INGELHEIM USA CORPORATION, INC.S RULE 7.1 DISCLOSURE STATEMENT AND CIVIL LOCAL RULE 3-15 CERTIFICATION OF INTERESTED ENTITIES OR PERSONS (Blaschke, Matthew)
|
|
| 21 | 21
NOTICE of Appearance by Matthew J. Blaschke FOR DEFENDANT BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. AND BOEHRINGER INGELHEIM USA CORPORATION, INC. (Blaschke, Matthew)
|
|
| 20 | 20
ORDER REASSIGNING CASE. Case reassigned to Judge Trina L Thompson for all further proceedings. Magistrate Judge Laurel Beeler no longer assigned to case,. Signed by Clerk on 4/5/2024. (ark, COURT STAFF)
|
|
| 19 | 19
CONSENT/DECLINATION to Proceed Before a US Magistrate Judge by GlaxoSmithKline, LLC.. (Bhimani, Jay)
|
|
| Thursday, April 04, 2024 | ||
| 18 | 18
ORDER GRANTING ADMINISTRATIVE MOTIONS TO CONSIDER WHETHER CASE SHOULD BE RELATED. Related Cases: 3:20-cv-03913, 4:24-cv-01903. Signed by Judge Trina L. Thompson on 4/4/2024. (rfm, COURT USER)
|
|
| Tuesday, April 02, 2024 | ||
| 17 | 17
CERTIFICATE OF SERVICE by GlaxoSmithKline, LLC re15 Stipulation (Bhimani, Jay)
|
|
| Monday, April 01, 2024 | ||
| 16 | 16
CERTIFICATE OF SERVICE by GlaxoSmithKline, LLC re12 Initial Case Management Scheduling Order with ADR Deadlines, (Bhimani, Jay)
|
|
| 15 | 15
STIPULATION to Extend Time to Answer or Otherwise Respond to Complaint filed by GlaxoSmithKline, LLC. (Bhimani, Jay)
|
|
| Friday, March 29, 2024 | ||
| 14 | 14
CERTIFICATE OF SERVICE by GlaxoSmithKline, LLC re10 Notice (Other),9 MOTION to Stay All Proceedings Pending Transfer to Multidistrict Litigation (Bhimani, Jay)
|
|
| 13 | 13
CLERK'S NOTICE Re: Consent or Declination: Plaintiffs/Defendants shall file a consent or declination to proceed before a magistrate judge. Note that any party is free to withhold consent to proceed before a magistrate judge without adverse substantive consequences. The forms are available at:[LINK:http://cand.uscourts.gov/civilforms] . Consent/Declination due by 4/5/2024 . (ejk, COURT STAFF)
|
|
| Thursday, March 28, 2024 | ||
| 12 | 12
Initial Case Management Scheduling Order with ADR Deadlines: Joint Case Management Statement due by 6/20/2024. Initial Case Management Conference set for 6/27/2024 at 11:00 AM in San Francisco - Videoconference Only. (tn, COURT STAFF)
|
|
| 11 | 11
CERTIFICATE OF SERVICE by GlaxoSmithKline, LLC re5 Certificate of Interested Entities,3 Notice of Appearance,2 Administrative Motion to Consider Whether Another Party's Material Should Be Sealed ,1 Notice of Removal,4 Notice of Appearance (Bhimani, Jay)
|
|
| 10 | 10
NOTICE by GlaxoSmithKline, LLC of Defendants' Notice of Related Case(Bhimani, Jay)
|
|
|
Att: 1
Exhibit A
|
||
| 9 | 9
MOTION to Stay All Proceedings Pending Transfer to Multidistrict Litigation filed by GlaxoSmithKline, LLC. Motion Hearing set for 5/2/2024 09:30 AM in San Francisco, Courtroom B, 15th Floor before Magistrate Judge Laurel Beeler. Responses due by 4/11/2024. Replies due by 4/18/2024.(Bhimani, Jay)
|
|
|
Att: 1
Proposed Order,
|
||
|
Att: 2
Exhibit A,
|
||
|
Att: 3
Exhibit B
|
||
| 8 | 8
Rule 7.1 Disclosures by Sanofi-Aventis U.S. LLC identifying Corporate Parent Sanofi for Sanofi-Aventis U.S. LLC. (Huynh, Tommy)
|
|
| Wednesday, March 27, 2024 | ||
| 7 | 7
RULE 7.1 DISCLOSURE STATEMENT AND CIVIL LOCAL RULE 3-15 CERTIFICATION OF INTERESTED ENTITIES OR PARTIES filed by Pfizer Inc. (Campagne, Ingrid)
|
|
| 6 | 6 Case assigned to Magistrate Judge Laurel Beeler. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening. Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 4/10/2024. (as, COURT STAFF) | |
| 5 | 5
RULE 7.1 DISCLOSURE STATEMENT AND CIVIL LOCAL RULE 3-15 CERTIFICATION OF INTERESTED ENTITIES OR PERSONS filed by GlaxoSmithKline, LLC identifying Corporate Parent GlaxoSmithKline plc for GlaxoSmithKline, LLC. (Bhimani, Jay)
|
|
| 4 | 4
NOTICE of Appearance by Mary H. Kim (Kim, Mary)
|
|
| 3 | 3
NOTICE of Appearance by Jay L. Bhimani (Bhimani, Jay)
|
|
| 2 | 2
Administrative Motion to Consider Whether Another Party's Material Should Be Sealed filed by GlaxoSmithKline, LLC.(Bhimani, Jay)
|
|
|
Att: 1
Proposed Order,
|
||
|
Att: 2
Exhibit 1,
|
||
|
Att: 3
Exhibit 2
|
||
| 1 | 1
NOTICE OF REMOVAL of Action Pursuant to 28 U.S.C. §§ 1332, 1441, and 1446 from Superior Court of Alameda County. Their case number is 23cv058495, (Filing Fee: $405.00, receipt number ACANDC-19263351). Filed by GlaxoSmithKline, LLC.(Bhimani, Jay) Modified on 3/28/2024 (tn, COURT STAFF).
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Exhibit C,
|
||
|
Att: 4
Exhibit D,
|
||
|
Att: 5
Exhibit E,
|
||
|
Att: 6
Civil Cover Sheet
|
||